| COVID-19 |
1 |
1 |
| Positron Emission Tomography |
0 |
0.82 |
| Cardiovascular Imaging |
0 |
0.73 |
| COVID-19 Vaccine |
0 |
0.64 |
| Hypertension |
0 |
0.45 |
| Cardiac MRI |
0 |
0.43 |
| Arrhythmia |
0 |
0.41 |
| Cardiovascular Risk Management |
0 |
0.99 |
| Blood |
0 |
0.3 |
| Heart |
0 |
0.3 |
| Biomarker |
0 |
0.22 |
| Biologic Therapy |
0 |
0.18 |
| Pain Management |
0 |
0.18 |
| Vaccines |
0 |
0.17 |
| Wound Management |
0 |
0.17 |
| Cardiovascular disease |
0 |
0.98 |
| Injury |
0 |
0.15 |
| Metabolism |
0 |
0.15 |
| Tissue |
0 |
0.15 |
| Pulmonary Embolism |
0 |
0.14 |
| Chest Pain |
0 |
0.13 |
| Ejection Fraction |
0 |
0.13 |
| Angina Pectoris |
0 |
0.12 |
| Deep Venous Thrombosis |
0 |
0.09 |
| Electronic Health Record (EHR) and Healthcare Technology |
0 |
0.09 |
| C-Reactive Protein (CRP) |
0 |
0.07 |
| Dyspnea |
0 |
0.07 |
| Edema |
0 |
0.07 |
| Exercise |
0 |
0.07 |
| Grant |
0 |
0.07 |
| Interleukin |
0 |
0.07 |
| Medical Innovations |
0 |
0.07 |
| Pain |
0 |
0.07 |
| Palpitations |
0 |
0.07 |
| Prognosis |
0 |
0.07 |
| Thorax |
0 |
0.07 |
| Troponin |
0 |
0.07 |